Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adults with Down Syndrome
10%
Aging
8%
AIDS Clinical Trials
5%
AIDS/HIV
21%
Alzheime's Disease
57%
Alzheimer's Disease
58%
Alzheimer's Disease Biomarkers
9%
Alzheimer's Disease Pathology
7%
Amyloid Positron Emission Tomography
5%
Antiretroviral Therapy
16%
Apolipoprotein E4 (APOE4)
7%
Autosomal Dominant Alzheimer's Disease
12%
Brain Aging
7%
Cardiac Magnetic Resonance Imaging (cMRI)
8%
Central Nervous System
9%
Cerebral Blood Flow
7%
Cerebrospinal Fluid
27%
Clinical Trials
6%
Cognitive Decline
8%
Cognitive Function
8%
Cognitive Impairment
14%
Cognitive Performance
6%
Cognitively Normal
10%
Combined Antiretroviral Therapy (cART)
12%
Dementia
12%
Depressive Symptoms
5%
Dominantly Inherited Alzheimer's Disease
5%
Down Syndrome
24%
Functional Connectivity
7%
Functional Magnetic Resonance Imaging
5%
HIV Infection
10%
HIV Neuropathy
6%
HIV+
6%
HIV-associated
5%
HIV-associated Neurocognitive Disorders
24%
HIV-infected Patients
12%
Human Immunodeficiency Virus Infection
6%
Human Immunodeficiency Virus Type 1 (HIV-1)
6%
Imaging Biomarkers
5%
Mild Cognitive Impairment
5%
Multiple Sclerosis
8%
Natalizumab
6%
Neurocognitive Impairment
7%
Neurodegeneration
10%
Neurofilament Light (NF-L)
6%
Neuroimaging
12%
Neurological Complications
6%
Neuropathic Pain
6%
Older Adults
17%
People Living with HIV (PLHIV)
24%
Peripheral Neuropathy
6%
Placebo
5%
Plasma Biomarkers
6%
Positron Emission Tomography/computed Tomography (PET/CT)
7%
Progressive multifocal Leukoencephalopathy
17%
Resting-state Functional Connectivity
6%
Sporadic Alzheimer's Disease
15%
Tau Pathology
6%
Tau PET
6%
Tau Positron Emission Tomography
6%
White Matter
9%
White Matter Hyperintensities
5%
Neuroscience
Alzheimer's Disease
83%
Amyloid Protein
33%
Behavior (Neuroscience)
5%
Biological Marker
33%
Blood Plasma
19%
CD4
6%
Central Nervous System
8%
Clinical Dementia Rating
5%
Cognitive Decline
5%
Cognitive Disorders
17%
Cognitive Function
5%
Cortical Thickness
5%
Down Syndrome
19%
Fluorine-18
7%
Functional Connectivity
12%
Functional Magnetic Resonance Imaging
8%
Gray Matter
6%
HIV Associated Dementia
18%
Human Immunodeficiency Virus
100%
Magnetic Resonance Imaging
19%
Metabolic Pathway
6%
Mild Cognitive Impairment
8%
Multiple Sclerosis
8%
Neurodegeneration
10%
Neurofilament Light Chain
5%
Neuropathy
16%
Older Adults
13%
Parkinson's Disease
5%
Positron Emission Tomography
15%
Positron Emission Tomography
12%
Progressive Multifocal Leukoencephalopathy
8%
Resting-State Functional Connectivity
7%
Risk Factor
5%
Somatosensory Cortex
5%
Medicine and Dentistry
Alzheimer's Disease
46%
Amyloid Protein
20%
Antiretroviral Therapy
6%
Autosomal Dominant Inheritance
9%
Biological Marker
17%
Cerebrospinal Fluid
10%
Clinical Trial
5%
Cognitive Defect
6%
Diseases
8%
Down Syndrome
16%
HIV-associated Neurocognitive Disorder
8%
Human Immunodeficiency Virus
33%
Human Immunodeficiency Virus Infection
5%
Magnetic Resonance Imaging
9%
Neuropathy
5%
Polyethylene Terephthalate
5%
Positron Emission Tomography
11%
Progressive Multifocal Leukoencephalopathy
6%
Tau
15%